You should have sold your Pfizer a while ago… their main cash cow patents expire soon and their pipeline isn’t exactly bursting with new potential blockbusters. Amgen and Novartis are much stronger plays in the industry right now (especially since Novartis is European, so it benefits if the dollar falls).
